With a revenue increase of 9.57% in the fourth quarter 2025, year on year to cumulative value of $70,725 million, Novartis Ag's revenue per employee grew on a trailing twelve months basis to $ 939,655. The productivity of Novartis Ag's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 129 other companies have achieved higher revenue per employee. While Novartis Ag's total ranking has deteriorated compared to the previous quarter from 0 to 1343. Novartis Ag has 75,267 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVS Revenue per Employee	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Revenue Change	9.57 %	-	12.32 %	-	10.85 %
Sales per Employee (TTM) $	939,655	873,862	873,862	853,389	853,389
NVS's Total Ranking	# 1343	# 0	#	#	#
Seq. Revenue Change	-	-	-	-	-

NVS Company Profile >> Back to NVS Efficiency Comparisons >> Compare NVS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 85
Healthcare Sector	# 130
Overall Market	# 1343

Revenue per Employee Statistics
High	Average	Low
$ 752,973	$ 683,404	$ 619,926
(Dec 31 2025)		(Dec 31 2023)

Financial Statements
Novartis Ag's Revenue MRQ	$ 56,674 Millions	Visit NVS's Income Statement
Novartis Ag's Revenues TTM	$ 70,725 Millions	Visit NVS's aggregate revenue growth
What are NVS's Sales?		Visit NVS's Sales by Segment

Other Ratios
Novartis Ag's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NVS's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NVS's Competitors
Revenue per Employee for NVS's Suppliers
Revenue per Employee for NVS's Customers

You may also want to know
NVS's Sales Growth Rates	NVS's Pe Price to earnings ratio	NVS's Receivables Turnover Ratio	NVS's Stock Quote
NVS's Net Income Growth Rates	NVS's Ps Price to Sales ratio	NVS's Sales per Employee	NVS's Asset Turnover Ratio
NVS's Net Margin	NVS's Pb Price to Book ratio	NVS's Financial Strength Ratios	NVS's Dividend Payout Ratio

Date modified: 2026-09-08T15:11:38+00:00

Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Dec 31 2025	Number of Employees Dec 31 2025
Cormedix Inc	1,590,770.76	$ 303.837 Million	191
Tg Therapeutics Inc	1,544,578.95	$ 616.287 Million	399
Arrowhead Pharmaceuticals Inc	1,534,431.79	$ 1,090.981 Million	711
Progyny Inc	1,505,238.32	$ 1,288.484 Million	856
Novavax inc	1,499,971.96	$ 1,123.479 Million	749
Xenetic Biosciences Inc	1,488,205.50	$ 2.976 Million	2
Alnylam Pharmaceuticals Inc	1,485,574.80	$ 3,713.937 Million	2,500
Bristol myers Squibb Company	1,482,892.31	$ 48,194.000 Million	32,500
Jazz Pharmaceuticals Plc	1,476,673.36	$ 4,267.586 Million	2,890
Nuvation Bio Inc	1,439,139.53	$ 61.883 Million	43
Neurocrine Biosciences Inc	1,430,250.00	$ 2,860.500 Million	2,000
Agenus Inc	1,409,827.16	$ 114.196 Million	81
Mirum Pharmaceuticals Inc	1,401,376.34	$ 521.312 Million	372
Valneva Se	1,397,272.00	$ 195.618 Million	140
Esperion Therapeutics Inc	1,371,207.48	$ 403.135 Million	294
Apellis Pharmaceuticals Inc	1,358,297.70	$ 1,003.782 Million	739
Acadia Pharmaceuticals Inc	1,342,738.10	$ 1,071.505 Million	798
Krystal Biotech Inc	1,319,084.75	$ 389.130 Million	295
Biogen Inc	1,318,746.67	$ 9,890.600 Million	7,500
Eli Lilly And Company	1,303,580.00	$ 65,179.000 Million	50,000
Lantheus Holdings Inc	1,291,661.36	$ 1,540.952 Million	1,193
Puma Biotechnology Inc	1,275,815.64	$ 228.371 Million	179
Fennec Pharmaceuticals Inc	1,275,485.71	$ 44.642 Million	35
Indivior Pharmaceuticals Inc	1,240,000.00	$ 1,240.000 Million	1,000
Amicus Therapeutics inc	1,238,410.96	$ 632.828 Million	511
Genmab A	1,228,128.10	$ 3,720.000 Million	3,029
Tarsus Pharmaceuticals Inc	1,219,891.89	$ 451.360 Million	370
Akebia Therapeutics Inc	1,217,505.15	$ 236.196 Million	194
Heron Therapeutics Inc	1,207,476.56	$ 154.557 Million	128
Theravance Biopharma inc	1,194,044.44	$ 107.464 Million	90

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.